| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Helmy A | Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. | 2006 | Aliment. Pharmacol. Ther. | pmid:16393276 |
| Freeman WS | When patients 'can't' take the pill. | 1978 | Am Fam Physician | pmid:146420 |
| Johnson GK et al. | Small intestinal disease, folate deficiency anemia, and oral contraceptive agents. | 1973 | Am J Dig Dis | pmid:4688570 |
| Valen-Sendstad A et al. | Effects of hormone therapy on depressive symptoms and cognitive functions in women with Alzheimer disease: a 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone. | 2010 | Am J Geriatr Psychiatry | pmid:20094015 |
| Parker WA et al. | Oral contraceptive-induced ischemic bowel disease. | 1979 | Am J Hosp Pharm | pmid:484572 |
| Mölsä PK | Inducement of therapeutic amenorrhea in mentally retarded women: two-year follow-up study. | 1986 | Am J Ment Defic | pmid:3953694 |
| Kane FJ et al. | Psychoendocrine study of oral contraceptive agents. | 1970 | Am J Psychiatry | pmid:4394090 |
| Moskovitz RA and Lingao A | Binge eating associated with oral contraceptives. | 1979 | Am J Psychiatry | pmid:434257 |
| Merz CN et al. | A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). | 2010 | Am. Heart J. | pmid:20569710 |
| Maleki M and Lange RL | Coronary thrombosis in young women on oral contraceptives: report of two cases and review of the literature. | 1973 | Am. Heart J. | pmid:4702663 |
| Strandberg TE et al. | Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women. | 2003 | Am. J. Cardiol. | pmid:12860228 |
| Waxler EB et al. | Myocardial infarction and oral contraceptive agents. | 1971 | Am. J. Cardiol. | pmid:4103945 |
| Yeung DL and Chan PL | Effects of a progestogen and a sequential type oral contraceptive on plasma vitamin A, vitamin E, cholesterol and triglycerides. | 1975 | Am. J. Clin. Nutr. | pmid:1146718 |
| Potera C and Rose DP | Effect of oral alanine loads on plasma amino acids in oral contraceptive users and control women. | 1978 | Am. J. Clin. Nutr. | pmid:645627 |
| Kanke Y et al. | Oral contraceptive steroids: effects on iron and zinc levels and on tryptophan pyrrolase and alkaline phosphatase activities in tissues of iron-deficient anemic rats. | 1980 | Am. J. Clin. Nutr. | pmid:7386413 |
| Crews MG et al. | Effects of oral contraceptive agents on copper and zinc balance in young women. | 1980 | Am. J. Clin. Nutr. | pmid:7416062 |
| Yeung DL | Effects of oral contraceptives on vitamin A metabolism in the human and the rat. | 1974 | Am. J. Clin. Nutr. | pmid:4812928 |
| Miller LT et al. | Vitamin B6 metabolism in women using oral contraceptives. | 1974 | Am. J. Clin. Nutr. | pmid:4211018 |
| Margen S and King JC | Effect of oral contraceptive agents on the metabolism of some trace minerals. | 1975 | Am. J. Clin. Nutr. | pmid:1119435 |
| Weininger J and King JC | Effect of oral contraceptive agents on ascorbic acid metabolism in the rhesus monkey. | 1982 | Am. J. Clin. Nutr. | pmid:7081122 |
| McLeroy VJ and Schendel HE | Influence of oral contraceptives on ascorbic acid concentrations in healthy, sexually mature women. | 1973 | Am. J. Clin. Nutr. | pmid:4122161 |
| Prasad AS et al. | Effect of oral contraceptive agents on nutrients: I. Minerals. | 1975 | Am. J. Clin. Nutr. | pmid:1119434 |
| Rivers JM and Devine MM | Plasma ascorbic acid concentrations and oral contraceptives. | 1972 | Am. J. Clin. Nutr. | pmid:5035056 |
| Grinspoon S et al. | Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa. | 2001 | Am. J. Clin. Nutr. | pmid:11333838 |
| Prasad AS et al. | Effect of oral contraceptive agents on nutrients: II. Vitamins. | 1975 | Am. J. Clin. Nutr. | pmid:1168019 |
| Jay S et al. | Riboflavin, self-report, and serum norethindrone. Comparison of their use as indicators of adolescent compliance with oral contraceptives. | 1984 | Am. J. Dis. Child. | pmid:6362397 |
| Ecker JA et al. | Thrombosis of the hepatic veins. "The Budd-Chiari syndrome"--a possible link between oral contraceptives and thrombosis formation. | 1966 | Am. J. Gastroenterol. | pmid:4952754 |
| Tran A et al. | Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study. | 1999 | Am. J. Gastroenterol. | pmid:10520843 |
| Barkin JS and Ross BS | Medical therapy for chronic gastrointestinal bleeding of obscure origin. | 1998 | Am. J. Gastroenterol. | pmid:9707046 |
| Iroh Tam PY et al. | Fatal case of bilateral internal jugular vein thrombosis following IVIg infusion in an adolescent girl treated for ITP. | 2008 | Am. J. Hematol. | pmid:17975805 |
| Squadrito F et al. | Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. | 2003 | Am. J. Med. | pmid:12727580 |
| Kalra TM et al. | Benign hepatic tumors and oral contraceptive pills. | 1976 | Am. J. Med. | pmid:188336 |
| Riggs BL | Formation-stimulating regimens other than sodium fluoride. | 1993 | Am. J. Med. | pmid:8256799 |
| Hoyumpa AM et al. | Budd-Chiari syndrome in women taking oral contraceptives. | 1971 | Am. J. Med. | pmid:5539574 |
| Li XZ and Zhou XT | Study of nucleolar organizer in women with galactorrhea, or polycystic ovaries, or using oral contraceptive. | 1983 | Am. J. Med. Genet. | pmid:6193710 |
| Bagdade JD et al. | Effects of serum from oral contraceptive users on the metabolism of low density lipoprotein. | 1987 | Am. J. Med. Sci. | pmid:3661617 |
| Shapiro SS et al. | Synthetic progestins: in vitro potency on human endometrium and specific binding to cytosol receptor. | 1978 | Am. J. Obstet. Gynecol. | pmid:717455 |
| Avoidance of dual publication. Statement by the Council of Biology Editors. | 1973 | Am. J. Obstet. Gynecol. | pmid:4681830 | |
| Hulka JF and Mohr K | Interference of cortisone-induced homograft survival by progestins. | 1967 | Am. J. Obstet. Gynecol. | pmid:5334310 |
| Judd HL | Gonadotropin-releasing hormone agonists: strategies for managing the hypoestrogenic effects of therapy. | 1992 | Am. J. Obstet. Gynecol. | pmid:1531578 |
| LEACH RB and MARGULIS RR | INHIBITION OF ADRENOCORTICAL RESPONSIVENESS DURING PROGESTIN THERAPY. | 1965 | Am. J. Obstet. Gynecol. | pmid:14310030 |
| Ansari AH and Beck PR | Pituitary-adrenocortical effect of short- and long-term progestational therapy. | 1969 | Am. J. Obstet. Gynecol. | pmid:4179212 |
| Beck LR et al. | New long-acting injectable microcapsule contraceptive system. | 1979 | Am. J. Obstet. Gynecol. | pmid:114054 |
| Gossain VV et al. | Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels. | 1983 | Am. J. Obstet. Gynecol. | pmid:6356926 |
| Higham JM and Shaw RW | A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia. | 1993 | Am. J. Obstet. Gynecol. | pmid:8238173 |
| Hammerstein J | Prodrugs: advantage or disadvantage? | 1990 | Am. J. Obstet. Gynecol. | pmid:2256526 |
| Dooley RR et al. | Polypoid cervicitis in cystic fibrosis patients receiving oral contraceptives. | 1974 | Am. J. Obstet. Gynecol. | pmid:4818428 |
| Zussman WV et al. | Ovarian morphology following cyclic norethindrone-mestranol therapy. | 1967 | Am. J. Obstet. Gynecol. | pmid:6034978 |
| Board JA | Continuous norethindrone, 0.35 mg., as an oral contraceptive agent. | 1971 | Am. J. Obstet. Gynecol. | pmid:5100077 |
| Barbieri RL | Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy. | 1990 | Am. J. Obstet. Gynecol. | pmid:2137979 |